secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2026-06-11T13:03:18+00:00
Accession:  0001628280-26-042396
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics stockholders elect Jeremy Levin as director, approve advisory say-on-pay and ratify KPMG as auditor
--------------------------------------------------------------------------------

- Jeremy M. Levin elected as director with 87,219,707 for, 8,528,008 withheld.
- Advisory say-on-pay approved: 84,511,953 for, 8,901,691 against, 2,334,071 abstain.
- Ratification of KPMG as independent auditor for FY2026 approved: 130,845,667 for, 32,505 against, 80,756 abstain.
- Quorum achieved with 130,958,928 shares present (75.7% of outstanding).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000162828026042396/0001628280-26-042396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000162828026042396/ovid-20260611.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-042396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer